User:Mr. Ibrahem/Mecasermin

Mecasermin, sold under the brand name Increlex, is medication used to treat growth failure in children due to primary insulin-like growth factor-I deficiency or lack of the gene for growth hormone. It is also being look at for amyotrophic lateral sclerosis. It is given by injection under the skin.

Common side effects include headache, low blood sugar, vomiting, lump at the site of injection, and middle ear infection. Other side effects may include enlarged tonsils, intracranial hypertension, and slipped capital femoral epiphysis. It is a recombinant form of human insulin-like growth factor-1 (rhIGF-1).

Mecasermin was approved for medical use in the United States in 2005 and Europe in 2007. In the United States 400 mg costs about 54,000 USD as of 2021. This amount in the United Kingdom costs the NHS about £24,000.